Efficacy and safety of TACE in combination with sorafenib for the treatment of TACE-refractory advanced hepatocellular carcinoma in Chinese patients: a retrospective study

References

• FornerALlovetJMBruixJHepatocellular carcinomaLancet201237998221245125522353262
   PubMed Web of Science ®Google Scholar
• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• KumarASrivastavaDNChauTTInoperable hepatocellular carcinoma: transarterial 188Re HDD-labeled iodized oil for treatment – prospective multicenter clinical trialRadiology2007243250951917456873
   PubMed Web of Science ®Google Scholar
• El-SeragHBRudolphKLHepatocellular carcinoma: epidemiology and molecular carcinogenesisGastroenterology200713272557257617570226
   PubMed Web of Science ®Google Scholar
• LencioniRChenXPDagherLVenookAPTreatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?Oncologist201015Suppl 4425221115580
   PubMed Web of Science ®Google Scholar
• NishikawaHKitaRKimuraTOsakiYTranscatheter arterial embolic therapies for hepatocellular carcinoma: a literature reviewAnticancer Res2014346877678625503113
   PubMed Web of Science ®Google Scholar
• KudoMTreatment of advanced hepatocellular carcinoma with emphasis on hepatic arterial infusion chemotherapy and molecular targeted therapyLiver Cancer201212627024159574
   PubMed Web of Science ®Google Scholar
• FacciorussoALicinioRMuscatielloNDiLABaroneMTransarterial chemoembolization: evidences from the literature and applications in hepatocellular carcinoma patientsWorld J Hepatol20157162009201926261690
   PubMedGoogle Scholar
• FuQHZhangQBaiXLSorafenib enhances effects of transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysisJ Cancer Res Clin Oncol201414081429144024770582
   PubMed Web of Science ®Google Scholar
• OhkiTSatoKYamagamiMEfficacy of transcatheter arterial chemoembolization followed by sorafenib for intermediate/advanced hepatocellular carcinoma in patients in Japan: a retrospective analysisClin Drug Investig20153511751759
   PubMedGoogle Scholar
• PinterMHuckeFGraziadeiIAdvanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenibRadiology2012263259059922438359
   PubMed Web of Science ®Google Scholar
• SergioACristoforiCCardinRTranscatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasivenessAm J Gastroenterol2008103491492118177453
   PubMed Web of Science ®Google Scholar
• ShimJHParkJWKimJHAssociation between increment of serum VEGF level and prognosis after transcatheter arterial chemoembolization in hepatocellular carcinoma patientsCancer Sci200899102037204419016764
   PubMed Web of Science ®Google Scholar
• YimHJSuhSJUmSHCurrent management of hepatocellular carcinoma: an Eastern perspectiveWorld J Gastroenterol201521133826384225852267
   PubMed Web of Science ®Google Scholar
• LlovetJMRealMIMontanaXArterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialLancet200235993191734173912049862
   PubMed Web of Science ®Google Scholar
• LlovetJMBruixJSystematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survivalHepatology200337242944212540794
   PubMed Web of Science ®Google Scholar
• WilhelmSMCarterCTangLBAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesisCancer Res200464197099710915466206
   PubMed Web of Science ®Google Scholar
• ChaoYChungYHHanGThe combination of transcatheter arterial chemoembolization and sorafenib is well tolerated and effective in Asian patients with hepatocellular carcinoma: final results of the START trialInt J Cancer201513661458146725099027
   PubMed Web of Science ®Google Scholar
• ChoiGHShimJHKimMJSorafenib alone versus sorafenib combined with transarterial chemoembolization for advanced-stage hepatocellular carcinoma: results of propensity score analysesRadiology2013269260361123864102
   PubMed Web of Science ®Google Scholar
• ZhouLLiJAiDLEnhanced therapeutic efficacy of combined use of sorafenib and transcatheter arterial chemoembolization for treatment of advanced hepatocellular carcinomaJpn J Clin Oncol201444871171724855686
   PubMedGoogle Scholar
• ZhangLHuPChenXBiePTransarterial chemoembolization (TACE) plus sorafenib versus TACE for intermediate or advanced stage hepatocellular carcinoma: a meta-analysisPLoS One20149e10030524945380
   PubMed Web of Science ®Google Scholar
• IkedaMMitsunagaSShimizuSEfficacy of sorafenib in patients with hepatocellular carcinoma refractory to transcatheter arterial chemoembolizationJ Gastroenterol201449593294023793266
   PubMed Web of Science ®Google Scholar
• OgasawaraSChibaTOokaYEfficacy of sorafenib in intermediate-stage hepatocellular carcinoma patients refractory to transarterial chemoembolizationOncology201487633034125227534
   PubMed Web of Science ®Google Scholar
• YamashitaTKanekoSTreatment strategies for hepatocellular carcinoma in JapanHepatol Res2013431445022583802
   PubMedGoogle Scholar
• LuoJGuoRPLaiECTransarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a prospective comparative studyAnn Surg Oncol201118241342020839057
   PubMed Web of Science ®Google Scholar
• IwasaSIkedaMOkusakaTTranscatheter arterial infusion chemotherapy with a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma refractory to transcatheter arterial chemoembolizationJpn J Clin Oncol201141677077521459893
   PubMedGoogle Scholar
• WuJBXuG-JLuY-SEfficacy of transcatheter arterial chemoembolization (TACE) combined with sorafenib in the treatment of advanced hepatocellular carcinomaAfr J Pharm Pharmacol2012725152519
   Google Scholar
• LencioniRLlovetJMModified RECIST (mRECIST) assessment for hepatocellular carcinomaSemin Liver Dis2010301526020175033
   PubMed Web of Science ®Google Scholar
• PawlikTMReyesDKCosgroveDKamelIRBhagatNGeschwindJFPhase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinomaJ Clin Oncol201129303960396721911714
   PubMed Web of Science ®Google Scholar
• ArizumiTUeshimaKMinamiTEffectiveness of sorafenib in patients with transcatheter arterial chemoembolization (TACE) refractory and intermediate-stage hepatocellular carcinomaLiver Cancer20154425326226734579
   PubMed Web of Science ®Google Scholar
• GeschwindJFKudoMMarreroJATACE treatment in patients with sorafenib-treated unresectable hepatocellular carcinoma in clinical practice: final analysis of GIDEONRadiology2016279263064026744927
   PubMed Web of Science ®Google Scholar
• WangGLiuYZhouSFSorafenib combined with transarterial chemoembolization in patients with hepatocellular carcinoma: a meta-analysis and systematic reviewHepatol Int201610350151026856326
   PubMed Web of Science ®Google Scholar
• ZeeneldinAASalemSETabashyRHIbrahimAAAlieldinNHTransarterial chemoembolization for the treatment of hepatocellular carcinoma: a single center experience including 221 patientsJ Egypt Natl Canc Inst201325314315023932751
   PubMedGoogle Scholar
• KudoMIzumiNKokudoNManagement of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated versionDig Dis201129333936421829027
   PubMed Web of Science ®Google Scholar
• LlovetJMBruixJMolecular targeted therapies in hepatocellular carcinomaHepatology20084841312132718821591
   PubMed Web of Science ®Google Scholar